Skip to main content
Interdisciplinary Toxicology logoLink to Interdisciplinary Toxicology
. 2019 Mar 2;11(2):115–121. doi: 10.2478/intox-2018-0007

Glutathione S-transferase is a good biomarker in acrylamide induced neurotoxicity and genotoxicity

Sreenivasulu Dasari 1,, Muni Swamy Ganjayi 1, Balaji Meriga 1
PMCID: PMC6829684  PMID: 31719782

Abstract

Glutathione S-transferases (GSTs) are major defence enzymes of the antioxidant enzymatic system. Cytosolic GSTs are more involved in the detoxification than mitochondrial and microsomal GSTs. GSTs are localized in the cerebellum and hippocampus of the rat brain. Acrylamide (AC) is a well assessed neurotoxin of both animals and humans and it produces skeletal muscle weakness and ataxia. AC is extensively used in several industries such as cosmetic, paper, textile, in ore processing, as soil conditioners, flocculants for waste water treatment and it is present in daily consumed food products, like potato chips, French fries, bread, breakfast cereals and beverages like coffee; it is detected on tobacco smoking. GST acts as a biomarker in response to acrylamide. AC can interact with DNA and therefore generate mutations. In rats, low level expression of glutathione S-trasferase (GST) decreases both memory and life span. The major aim of this review is to provide better information on the antioxidant role of GST against AC induced neurotoxicity and genotoxicity.

Keywords: glutathione S-transferases, biomarker, acrylamide, neurotoxicity, genotoxicity

Introduction

Glutathione S-transferases (GSTs) (EC 2.5.1.18) are multifunctional phase II versatile detoxification and xenobiotic metabolizing enzymes (Hayes et al., 2005; Frova, 2006). There are seven classes of cytosolic glutathione S-transferases identified in mammals, which are classified on the basis of amino acid sequence similarities, named as alpha (α), mu (μ), pi (π), sigma (σ), theta (θ), omega (ω) and zeta (ξ) (Hayes & McLellan, 1999; Sheehan et al., 2001).

Detoxification role of GST

The cytosolic GST isoenzymes belong to the same class sharing greater than 40% identity. Between different classes the identity is less than 25% (Hayes et al., 2005). GSTs are ubiquitous and inactivation of cancerous agents through metabolism makes them important in cancer therapy (certainly alpha, mu, pi and theta class GSTs) (Lo et al., 2007). The tri-peptide glutathione (GSH) is an efficient scavenger of reactive oxygen species (ROS). GSTs are responsible for detoxification of oxidative stress by products of metabolism (Hayes et al., 2005). Toxic chemicals, oxidation and variation in temperature can regulate the expression of GSTs (Frova, 2006). The conjugation of electrophilic compounds by GST with glutathione detoxifies harmful drugs and environmental chemicals and thus GSTs are toxicologically important enzymes (Arakawa et al., 2013). Figure 1, shows general reaction catalysed by GST. GSTs are playing a key role in cellular detoxification system to protect the cell from reactive oxygen metabolites and they contribute to biotransformation of xenobiotics and carcinogens (Hayes et al., 2005). GST based drugs would be the next generation therapeutics to deal with drug resistance, cancer as well as neurological and neurodegenerative diseases (Kumar et al., 2017).

Figure 1.

Figure 1

General reaction catalyzed by glutathione S-transferases.

GST enzymes have developed many functions throughout evolution (da Fonesca et al., 2010). The cellular protective role of GST superfamily was taken towards positive selection on GST duplicates and they acquired other functions including sex hormone metabolism and apoptosis regulation which are vital for the retention of duplicates. Metabolism of xenobiotics was the main cause for the expansion of the GST family (da Fonesca et al., 2010).

GSTs exhibit an adaptive response to cellular stress (Hayes et al., 2005). In addition, cytosolic GST promoter possesses the antioxidant response element (Frova, 2006). Glutathione (GSH) acts as scavenger of reactive oxygen species (ROS) and GSTs are responsible for metabolism of oxidative stress by-products (Hayes et al., 2005). It was identified that soluble GSTs in mitochondria may work against reactive oxygen species (ROS) generated by the respiratory chain (Haider et al., 2002). GST binding to reactive electrophiles may be important for preventing DNA damage. Ffor other molecules GSTs act as intracellular carriers (Hayes et al., 2005). GSTs are multifunctional antioxidant enzymes that exhibit selenium independent glutathione peroxidase (GPx) activity in addition to glutathione transferase (GST) activity. With these activities GST can detoxify a variety of toxic chemicals (Dasari et al., 2017a)

Structural characterization of GST

Ther are two binding sites in the cytosolic glutathione S-transferases (GSTs), i.e. glutathione (GSH) binding site (G site) and substrate (xenobiotic) binding site (H site). Two distinct xenobiotic binding sites are there in rat alpha class GST, including certain GST isoenzymes (Ding et al., 2003).

It is suggested that domain I (G site) is composed of smaller N-terminal α/β helices, which include 1–78 amino acid residues of α and θ class, 1–82 of class μ, 1–74 of class π and σ and domain II (H site) is composed of larger α helix, which includes 86–222 amino acid residues of class α, 90–217 of class μ, 81–207 of class π, 81–202 of class σ and 85–208 of class θ (Armstrong, 1994; Wilce et al., 1995). GST specific activity is decided by amino acid residues in the H-site (Armstrong, 1994).

Brain GSTs

Table 1 shows localization and importance of GST. Several studies reported that alpha (α), mu (μ) and pi (π) class GSTs were purified from rat brain; Yc of α class, Yb and Yβ of μ class, Yδ of π class GSTs with relevant molecular weight 27.5 KD, 26.3 KD and 26 KD, and 24.8 KD respectively, are expressed in response to toxic chemicals. Increased levels of total GST activity and relative density of that enzyme was studied in two regions of the brain, i.e. cerebellum and hippocampus (Struzynska et al., 2002). The π class GST has been associated with myelin forming cell, probably to protect the myelin structure (Tansey & Cammer, 1991). Several studies reported that Yb and Yβ subunits of π class GST are more expressed in the rat brain, which may play a key role in detoxification. According to brain immunohistochemical studies, GSTA4 is predominantly distributed in ependymal cells of the chorioid plexus, endothelial cells and perivascular endfeet of astrocytes (Johnson et al., 1993). The GSTA4 isoenzyme in the blood-brain barrier was strategically positioned to defend the microenvironment of brain cells (Abbott et al., 2006). The GSTA4 expression levels were increased and nearly doubled in the cerebral cortex of old rats compared to young adult rats (Martinez-Lara et al., 2003). The absence of GSTM1 increases the risk of schizophrenia and tardive dyskinesia (De Leon et al., 2005). The mood stabilizers, like lithium or valproate, induce expression of both GSTM1 and GSTA4 and they inhibit oxidative damage to lipids and proteins and thus protect the brain from exotoxicity (Shao et al., 2005). A low level of GST expression is associated with a decrease of life span memory performances in rats and it may model assessment of brain aging and neurodegeneration (Bjork et al., 2006).

Table 1.

Rat brain glutathione S-transferases localization and their role.

Yb3 subunit of μ class GST is specifically expressed in rat brain Abramovitz & Listowsky, 1987
GST isoenzymes are localized in glial cells of rat brain Cammer et al., 1989
π class GST may protect myelin structure Tansey & Cammer, 1991
GSTA4 of alpha (α) class is localized in ependymal cells of the chorioid plexus, endothelial cells and perivascular endfeet of astrocytes Johnson et al., 1993
Ya subunit in nuclei and Yc subunit in nucleoli of α class GST is localized in rat brain neuron
Both α and μ class GSTs protect neurons from toxic compounds
GST activity is identified in detectable level in both cerebellum and hippocampus Struzynska et al., 2002
GSTA4 and GSTM1 of α and μ class GSTs inhibit oxidative damage to lipids and proteins in rat brain Shao et al., 2005
GSTA4 isoenzyme may protect microenvironment of brain cell Abbott et al., 2006
Absence of GSTM1 of π class GST is increase the risk of schizophrenia and tardive dyskinesia De Leon et al., 2005
Low level expression of GST decrease life span and memory Bjork et al., 2006

Immunohistochemical studies reported μ class GST to be localized in astrocytes, subventricular zone cells and ependymal cells (Cammer et al., 1989), π class GST is localized in oligodendrocytes and also in association with myelin (Cammer et al., 1989) of the rat brain central nervous system. Localization of GST Ya subunit was identified in nuclei and Yc subunit in nucleoli of the rat brain neuron (Johnson et al., 1993). There are at least two GST isoenzymes localized in glial cells of the rat brain (Cammer et al., 1989). Yb3 subunit of μ class GST was found to be specifically expressed in the rat brain (Abramovitz & Listowsky, 1987).

Cytosolic GST activity and total concentration of GST protein as well as the concentration of μ class GST are almost equal in the cerebellar cortex of the rat (Johnson et al., 1993). In rats, the cytoplasmic localization of microsomal GST and the nuclear localization of α class GSTs in neurons, the relationship between the concentration of Yb2 subunit of μ class GST and also the resistance of neurons to toxic compounds in the cerebellar cortex indicate that the GSTs may protect against exogenous as well as endogenous neurotoxic metabolites (Johnson et al., 1993).

Role of biomarkers

The environment is continuously loaded by foreign chemicals as well as metals due to urbanization and industrialization. From the beginning of the 20th century several thousands of organic pollutants have been by several ways released into the environment (Helm et al., 2011). Most of these chemicals are undegradable, extremely toxic and accumulated both in territorial and aquatic ecosystems, transported to different environments by air, water and migratory species from their production place (Choi & Wania, 2011). Biochemical markers are useful in examining the effects of toxicants in various tissues (Van der Oost et al., 2003). Figure 2, shows the expression of GST in response to AC. Biochemical markers can provide basic warning signals of particular stress and also give information on the health status of the organism (Korte et al., 2000).

Figure 2.

Figure 2

Xenobiotic versus GST in cell.

By ecotoxicological studies the interaction between chemicals and the organism can be assessed at different levels by using various biomarkers such as biotransformation enzymes, antioxidative compounds, oxidative stress parameters, biotransformation products, stress proteins, both hematological and histological parameters, immunological, reproductive and endocrine parameters, genotoxic, neuromuscular, physiological and morphological and many other parameters (Van der Oost et al., 2003). Most of the xenobiotics are metabolized by conjugation with glutathione (GSH) catalyzed by glutathione-S-transferase (GST) (Zimniak, 2008). A variety of organic xenibiotics, drugs and toxic compounds are matabolized by glutathione S-transferases (Halliwell & Gutterdige, 2015). In response to xenobiotics, the expression of GST as biomarker can be measured with the substrate 1-chloro-2, 4-dinitrobenzene by a using spectrophotometer (Habig et al., 1974).

Acrylamide (AC)

Acrylamide (AC) is a very reactive and easily soluble substance in water and it is commonly used in industries as well as laboratories (Nordin et al., 2003). As shown in Figure 3, AC is used in cosmetic, paper and textile industries as well as in ore processing, as soil conditioners and flocculants for waste water treatment (Friedman, 2003). AC is carcinogenic to experimental animals; it was discovered in various food products which are routinely consumed by humans, a situation raised public health concerns (Weiss, 2002). Generally, individuals can be victimized to AC at the work place (Dearfield et al., 1995). AC enters the human diet through carbohydrate and amino acid rich food products prepared at high temperature (during food processing) (Stadler et al., 2002; Mottram et al., 2002); heat treated food products contain AC (Konings et al., 2003). Lower level of AC is formed when cooking at lower temperature (Rydberg et al., 2003). As shown in Figure 3, commonly consumed foods such as breakfast cereals, French fries and potato chips, as well as beverages (e.g., coffee) contain a significant quantity of AC (Tareke et al., 2002).

Figure 3.

Figure 3

Sources of acrylamide (AC) toxicity.

It is well established that AC once entered into the biological system is quickly passed via cell membranes and widely distributed to all tissues (LoPachin & DeCaprio, 2005). AC shows neurotoxic, mutagenic and carcinogenic effects (Zhang et al, 2011; Maier et al., 2012). AC forms glutathione S-conjugate by interacting with vital cellular nucleophiles having -SH, -NH2 and -OH groups, which is an initial step of biotransformation of electrophiles to mercapturic acid (Awad et al., 1998). AC interacts with glutathione S-trsansferases (GSTs) (Das et al., 1982). AC induced oxidative stress is more effective at high doses (Yousef & El-Demerdash, 2006).

Influence of AC on GST

A significant decrease in glutathione (GSH) content and GST activity was observed in AC administered rat brain (Shukla et al., 2002). Depletion of GSH content as well as inhibition of GST activity was found both in vitro and in vivo (Srivastava et al., 1986). A high level of GST and GST associated peroxidase (GPx) can protect the brain from AC toxicity up to certain level (Dasari et al., 2017b).

Neurotoxicity of AC

The occurrence of adverse changes at the structural and functional level in the nervous system induced by a toxic compound is considered neurotoxicity and the substance responsible for the pathological condition of the nervous system is a neurotoxin (Bull, 2007). AC induced neurotoxic symptoms are characterized as ataxia, skeletal muscle weakness, and cognitive impairment including numbness of the extremities (Deng et al., 1993). AC neurotoxicity in both human and experimental models was associated with cerebellar Purkinje cell death, degeneration of distal axons and nerve terminals in both the peripheral and central nervous systems (PNS and CNS) (LoPachin et al., 2003).

Several rat studies suggest that axon degeneration might not be a primary neurotoxic effect of AC (Lehning et al., 2003). Long-term treatment and low-dose administration of AC lead to degeneration of peripheral nerve tissue such as sciatic, tibial and sural nerves. Silver stain study of rat cerebellum revealed that AC can induce progressive degeneration of Purkinje cell axons (Lehning et al., 2003). Central-peripheral neuropathy was observed in rats, monkeys and humans exposed to AC (Seale et al., 2012). Allam et al. (2013) identified AC toxicity in the cerebral cortex as pyknosis and neurocyte chromatolysis in all stages of their investigation.

When the adduct formation exceeds and intoxication continues up to a disproportional increase of dysfunctional proteins, the related presynaptic processes are progressively disabled, which leads to the characteristic cumulative neurotoxicity of AC (LoPachin et al., 2006). AC was found to suppress both metabolism and axonal transport in neurons, which leads to deficiency of nutritional factors (Honing & Rosenberg, 2000). Both prenatal and perinatal exposure of rodent pups to AC causes developmental neurotoxicity (Garey & Paule, 2010). The accumulation of weak type-2 alkene electrophiles such as AC, methyl acrylate, ethyl methacrylate accelerate the progressive nerve terminal demise associated with Alzheimer’s disease (LoPachin & Gavin, 2012). Both cerebellar dysfunctions and proprioceptive sensations are causes for abnormal performances after AC administration (Allam et al., 2011).

Genotoxicity of AC

Toxicogenomic studies are based on gene expression evaluation to detect toxicity signals and identify new sensitive markers (Ellinger-Ziegelbauer et al., 2008). Yet the specificity of thousands of genomic biomarkers are sometimes confuse and thereby not significant enough (Zhang et al., 2011). When gametes are subjected to artificial reactive oxygen species (ROS) DNA damage may occur, such as modification of all bases, generation of base-free sites, deletions, frameshifts, DNA cross links, including chromosomal rearrangements (Duru et al., 2000). Figure 2 shows the expression GST in response to AC.

DNA adduct formation is completely non-dose dependent and mutations can form at lower concentrations of AC, indicating the generation of promutagenic DNA adducts (Besaratinia & Pfeifer, 2003). Both AC and glycidamide (GC) (epoxide metabolite of AC) can damage DNA and glycidamide is mainly responsible for the mutagenicity of AC (Besaratinia & Pfeifer, 2004). Even micromolar doses of AC can effectively induce promutagenic DNA adducts and this calls for a reconsideration of AC presence in human diet as well as in the environment (Besaratinia & Pfeifer, 2004).

Adler et al. (1993) suggested that AC can generate chromosomal aberrations, sister chromatid exchanges, and mitotic disturbances. Both chromosomal aberration and micronucleus assays proved that AC might have genotoxic potency (Yang et al., 2005). In AC treated rats, feulgen stain (specific for DNA) color intensity is decreased in the medulla neurons when compared to control, due to a marked loss of DNA in the medulla neurons (Allam et al., 2013). During the process of apoptosis, serious and irreversible DNA damage occurs. Glutathione S-transferases and its peroxidase activities are destabilized by the excess accumulation of AC, leading to interaction with DNA (Sreenivasulu & Balaji, 2016).

Conclusion

This review summarizes the neuro and geno-toxicity of AC and the important role of GSTs in detoxification of toxic chemical agents like AC, and their localization in the brain, i.e. the cerebellum, hippocampus, neurons and glial cells. AC is a neurotoxin with symptoms like ataxia, skeletal muscle weakness, cognitive impairment and numbness. AC is a potent genotoxic agent forming chromosomal aberrations and micronuclei. Glutathione conjugation with toxic agents, catalyzed by GSTs, is the most important phase of detoxification. High expression of GST in cytotoxic conditions reveals that it is an efficient biomarker and enhances more tolerance of biological systems to toxic chemicals.

Acknowledgements

The authors are thankful to the University Grants Commission, New Delhi, India (Grant No: PDFSS-2011-12-SC-AND-3355) for providing Financial Assistance.

REFERENCES

  1. Abbott NJ, Rönnbäck L, Hansson E. Astrocyte–endothelial interactions at the blood–brain barrier. Nat Rev Neurosci. 2006;7(1):41–53. doi: 10.1038/nrn1824. [DOI] [PubMed] [Google Scholar]
  2. Abramovitz M, Listowsky I. Selective expression of a unique glutathione S-transferase Yb3 gene in rat brain. Journal of Biological Chemistry. 1987;262(16):7770–7773. [PubMed] [Google Scholar]
  3. Adler ID, Zouh R, Schmid E. Perturbation of cell division by acrylamide in vitro and in vivo. Mutat Res. 1993;301(4):249–54. doi: 10.1016/0165-7992(93)90065-4. [DOI] [PubMed] [Google Scholar]
  4. Allam A, El-Ghareeb AA, Abdul-Hamid M, Baikry A, Sabri MI. Prenatal and perinatal acrylamide disrupts the development of cerebellum in rat: biochemical and morphological studies. Toxicol Ind Health. 2011;27(4):1–16. doi: 10.1177/0748233710386412. [DOI] [PubMed] [Google Scholar]
  5. Allam AA, Abdul-Hamid M, Bakry A, El-Ghareeb A, Ajarem JS, Sabri M. Effect of acrylamide on cerebral neurons development in albino rat. Life Sci. 2013;10(3):1814–1825. [Google Scholar]
  6. Armstrong RN. Glutathione S‐Transferases: Structure and Mechanism of an Archetypical Detoxication Enzyme. Adv Enzymol Relat Areas Mol Biol. 1994;69:1–44. doi: 10.1002/9780470123157.ch1. [DOI] [PubMed] [Google Scholar]
  7. Arakawa S. Utilization of glutathione S-transferase Mu 1-and Theta 1-null mice as animal models for absorption, distribution, metabolism, excretion and toxicity studies. Expert Opin Drug Metab Toxicol. 2013;9(6):725–736. doi: 10.1517/17425255.2013.780027. [DOI] [PubMed] [Google Scholar]
  8. Awad ME, Abdel-Rahman MS, Hassan SA. Acrylamide toxicity in isolated rat hepatocytes. Toxicol In Vitro. 1998;12(6):699–704. doi: 10.1016/s0887-2333(98)00051-4. [DOI] [PubMed] [Google Scholar]
  9. Besaratinia A, Pfeifer GP. Weak yet distinct mutagenicity of acrylamide in mammalian cells. J Natl Cancer Inst. 2003;95(12):889–896. doi: 10.1093/jnci/95.12.889. [DOI] [PubMed] [Google Scholar]
  10. Besaratinia A, Pfeifer GP. Genotoxicity of acrylamide and glycidamide. J Natl Cancer Inst. 2004;96(13):1023–1029. doi: 10.1093/jnci/djh186. [DOI] [PubMed] [Google Scholar]
  11. Björk K, Saarikoski ST, Arlinde C, Kovanen L, Osei-Hyiaman D, Ubaldi M, Reimers M, Hyytiä P, Heilig M, Sommer WH. Glutathione-S-transferase expression in the braIn: possible role in ethanol preference and longevity. FASEB J. 2006;20(11):1826–1835. doi: 10.1096/fj.06-5896com. [DOI] [PubMed] [Google Scholar]
  12. Bull S. Review of Environmental Chemicals and Neurotoxicity: Focus on Neurological Diseases. Health Protection Agency, Govt. of UK; 2007. [Google Scholar]
  13. Cammer W, Tansey F, Abramovitz M, Ishigaki S, Listowsky I. Differential localization of glutathione‐S‐transferase Yp and Yb subunits in oligodendrocytes and astrocytes of rat brain. J Neurochem. 1989;52(3):876–883. doi: 10.1111/j.1471-4159.1989.tb02536.x. [DOI] [PubMed] [Google Scholar]
  14. Choi SD, Wania F. On the reversibility of environmental contamination with persistent organic pollutants. Environ Sci Technol. 2011;45(20):8834–8841. doi: 10.1021/es2017544. [DOI] [PubMed] [Google Scholar]
  15. da Fonseca RR, Johnson WE, O’Brien SJ, Vasconcelos V, Antunes A. Molecular evolution and the role of oxidative stress in the expansion and functional diversification of cytosolic glutathione transferases. BMC Evol Biol. 2010;10(1):281. doi: 10.1186/1471-2148-10-281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Das M, Mukhtar H, Seth PK. Effect of acrylamide on brain and hepatic mixed-function oxidases and glutathione-S-transferase in rats. Toxicol Appl Pharmacol. 1982;66(3):420–6. doi: 10.1016/0041-008x(82)90308-8. [DOI] [PubMed] [Google Scholar]
  17. Dasari S, Ganjayi MS, Oruganti L, Balaji H, Meriga B. Glutathione S-transferases Detoxify Endogenous and Exogenous Toxic Agents - Minireview. JDVAR. 2017a;5(5):00154. [Google Scholar]
  18. Dasari S, Ganjayi MS, Meriga B, Kedam T. Developmental neurotoxicity of acrylamide: defensive role of chick embryo glutathione S-transferases. Adv Anim Vet Sci. 2017b;5(7):299–306. [Google Scholar]
  19. Dearfield KL, Douglas GR, Ehling UH, Moore MM, Sega GA, Brusick DJ. Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk. Mutat Res. 1995;330(1):71–99. doi: 10.1016/0027-5107(95)00037-j. [DOI] [PubMed] [Google Scholar]
  20. de Leon J, Susce MT, Pan RM, Koch WH, Wedlund PJ. Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness. J Clin Psychopharmacol. 2005;25(5):448–456. doi: 10.1097/01.jcp.0000177546.34799.af. [DOI] [PubMed] [Google Scholar]
  21. Deng H, He F, Zhang S, Calleman CJ, Costa LG. Quantitative measurements of vibration threshold in healthy adults and acrylamide workers. Int Arch Occup Environ Health. 1993;65(1):53–56. doi: 10.1007/BF00586059. [DOI] [PubMed] [Google Scholar]
  22. Ding Y, Ortelli F, Rossiter LC, Hemingway J, Ranson H. The Anopheles gambiae glutathione transferase supergene family: annotation, phylogeny and expression profiles. BMC Genomics. 2003;4(1):35. doi: 10.1186/1471-2164-4-35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Duru NK, Morshedi M, Oehninger S. Effects of hydrogen peroxide on DNA and plasma membrane integrity of human spermatozoa. Fertil Steril. 2000;74(6):1200–1207. doi: 10.1016/s0015-0282(00)01591-0. [DOI] [PubMed] [Google Scholar]
  24. Ellinger-Ziegelbauer H, Gmuender H, Bandenburg A, Ahr HJ. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. Mutat Res. 2008;637(1):23–39. doi: 10.1016/j.mrfmmm.2007.06.010. [DOI] [PubMed] [Google Scholar]
  25. Frova C. Glutathione transferases in the genomics era: new insights and perspectives. Biomol Eng. 2006;23(4):149–169. doi: 10.1016/j.bioeng.2006.05.020. [DOI] [PubMed] [Google Scholar]
  26. Friedman M. Chemistry, biochemistry, and safety of acrylamide. A review. J Agric Food Chem. 2003;51(16):4504–4526. doi: 10.1021/jf030204+. [DOI] [PubMed] [Google Scholar]
  27. Garey J, Paule MG. Effects of chronic oral acrylamide exposure on incremental repeated acquisition (learning) task performance in Fischer 344 rats. Neurotoxicol Teratol. 2010;32(2):220–225. doi: 10.1016/j.ntt.2009.10.001. [DOI] [PubMed] [Google Scholar]
  28. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases the first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249(22):7130–7139. [PubMed] [Google Scholar]
  29. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51–88. doi: 10.1146/annurev.pharmtox.45.120403.095857. [DOI] [PubMed] [Google Scholar]
  30. Hayes JD, Mclellan LI. Glutathione and glutathione-dependent enzymes represent a coordinately regulated defence against oxidative stress. Free Radic Res. 1999;31(4):273–300. doi: 10.1080/10715769900300851. [DOI] [PubMed] [Google Scholar]
  31. Hayes JD, Pulford DJ. The glut athione S-transferase supergene family: regulation of GST and the contribution of the lsoenzymes to cancer chemoprotection and drug resistance part II. Crit Rev Biochem Mol Biol. 1995;30(6):521–600. doi: 10.3109/10409239509083491. [DOI] [PubMed] [Google Scholar]
  32. Halliwell B, Gutteridge JM. Free radicals in biology and medicine. USA: Oxford University Press; 2015. [Google Scholar]
  33. Helm PA, Milne J, Hiriart-Baer V, Crozier P, Kolic T, Lega R, Chen T, MacPherson K, Gewurtz S, Winter J, Myers A. Lake-wide distribution and depositional history of current-and past-use persistent organic pollutants in Lake Simcoe, Ontario, Canada. J Great Lakes Res. 2011;37:132–141. [Google Scholar]
  34. Hiratsuka A, Yokoi A, Sebata N, Watabe T, Hatayama I, Sato K. Glutathione conjugation of the fluorophotometric epoxide substrate, 7-glycidoxycoumarin (GOC), by rat liver glutathione transferase isoenzymes. Biochem Pharmacol. 1989;38(16):2609–2613. doi: 10.1016/0006-2952(89)90545-5. [DOI] [PubMed] [Google Scholar]
  35. Honig LS, Rosenberg RN. Apoptosis and neurologic disease. The Am J Med. 2000;108(4):317–330. doi: 10.1016/s0002-9343(00)00291-6. [DOI] [PubMed] [Google Scholar]
  36. Johnson JA, el Barbary AI, Kornguth SE, Brugge JF, Siegel FL. Glutathione S-transferase isoenzymes in rat brain neurons and glia. J Neurosci. 1993;13(5):2013–2023. doi: 10.1523/JNEUROSCI.13-05-02013.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Konings EJ, Baars AJ, Van Klaveren JD, Spanjer MC, Rensen PM, Hiemstra M, Van Kooij JA, Peters PW. Acrylamide exposure from foods of the Dutch population and an assessment of the consequent risks. Food Chem Toxicol. 2003;41(11):1569–1579. doi: 10.1016/s0278-6915(03)00187-x. [DOI] [PubMed] [Google Scholar]
  38. Korte F, Kvesitadze G, Ugrekhelidze D, Gordeziani M, Khatisashvili G, Buadze O, Zaalishvili G, Coulston F. Organic toxicants and plants. Ecotoxicology and environmental safety. 2000;47(1):1–26. doi: 10.1006/eesa.2000.1929. [DOI] [PubMed] [Google Scholar]
  39. Kumar A, Dhull DK, Gupta V, Channana P, Singh A, Bhardwaj M, Ruhal P, Mittal R. Role of Glutathione-S-transferases in neurological problems. Expert Opin Ther Pat. 2017;27(3):299–309. doi: 10.1080/13543776.2017.1254192. [DOI] [PubMed] [Google Scholar]
  40. Lehning EJ, Balaban CD, Ross JF, LoPachin RM. Acrylamide neuropathy: II. Spatiotemporal characteristics of nerve cell damage in brainstem and spinal cord. Neurotoxicology. 2003;24(1):109–23. doi: 10.1016/s0161-813x(02)00192-4. [DOI] [PubMed] [Google Scholar]
  41. Lo HW, Ali-Osman F. Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr Opin Pharmacol. 2007;7(4):367–374. doi: 10.1016/j.coph.2007.06.009. [DOI] [PubMed] [Google Scholar]
  42. LoPachin RM, Balaban CD, Ross JF. Acrylamide axonopathy revisited. Toxicol Appl Pharmacol. 2003;188(3):135–153. doi: 10.1016/s0041-008x(02)00072-8. [DOI] [PubMed] [Google Scholar]
  43. LoPachin RM, DeCaprio AP. Protein adduct formation as a molecular mechanism in neurotoxicity. Toxicol Sci. 2005;86(2):214–225. doi: 10.1093/toxsci/kfi197. [DOI] [PubMed] [Google Scholar]
  44. LoPachin RM, Barber DS, He D, Das S. Acrylamide inhibits dopamine uptake in rat striatal synaptic vesicles. Toxicol Sci. 2006;89(1):224–234. doi: 10.1093/toxsci/kfj005. [DOI] [PubMed] [Google Scholar]
  45. LoPachin RM, Gavin T. Molecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistry. Environ Health Perspect. 2012;120(12):1650–1657. doi: 10.1289/ehp.1205432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Maier A, Kohrman-Vincent M, Hertzberg R, Allen B, Haber LT, Dourson M. Critical review of dose–response options for F344 rat mammary tumors for acrylamide–Additional insights based on mode of action. Food Chem Toxicol. 2012;50(5):1763–1775. doi: 10.1016/j.fct.2012.02.002. [DOI] [PubMed] [Google Scholar]
  47. Mannervik B, Danielson UH, Ketterer B. Glutathione transferases—structure and catalytic activity. CRC Crit Rev Biochem. 1988;23(3):283–337. doi: 10.3109/10409238809088226. [DOI] [PubMed] [Google Scholar]
  48. Mannervik B. Glutathione and the evolution of enzymes for detoxication of products of oxygen metabolism. Chemica Scripta. 1986;263:281–284. [Google Scholar]
  49. Martinez-Lara E, Siles E, Hernández R, Cañuelo AR, del Moral ML, Jiménez A, Blanco S, López-Ramos JC, Esteban FJ, Pedrosa JA, Peinado MA. Glutathione S-transferase isoenzymatic response to aging in rat cerebral cortex and cerebellum. Neurobiol Aging. 2003;24(3):501–509. doi: 10.1016/s0197-4580(02)00139-2. [DOI] [PubMed] [Google Scholar]
  50. Mottram DS, Wedzicha BL, Dodson AT. Food chemistry: acrylamide is formed in the Maillard reaction. Nature. 2002;419(6906):448–449. doi: 10.1038/419448a. [DOI] [PubMed] [Google Scholar]
  51. Nordin-Andersson M, Walum E, Kjellstrand P, Forsby A. Acrylamide-induced effects on general and neurospecific cellular functions during exposure and recovery. Cell Biol Toxicol. 2003;19(1):43–51. doi: 10.1023/a:1022017731328. [DOI] [PubMed] [Google Scholar]
  52. Haider RA, Robin MA, Fang JK, Avadhani NG. Multiple isoforms of mitochondrial glutathione S-transferases and their differential induction under oxidative stress. Biochem J. 2002;366(1):45–55. doi: 10.1042/BJ20020533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Rydberg P, Eriksson S, Tareke E, Karlsson P, Ehrenberg L, Törnqvist M. Investigations of factors that influence the acrylamide content of heated foodstuffs. J Agric Food Chem. 2003;51(24):7012–7018. doi: 10.1021/jf034649+. [DOI] [PubMed] [Google Scholar]
  54. Satoh K, Hatayama I, Tsuchida S, Sato K. Biochemical characteristics of a preneoplastic marker enzyme glutathione S-transferase P-form (7-7) Arch Biochem Biophys. 1991;285(2):312–316. doi: 10.1016/0003-9861(91)90365-p. [DOI] [PubMed] [Google Scholar]
  55. Seale SM, Feng Q, Agarwal AK, El-Alfy AT. Neurobehavioral and transcriptional effects of acrylamide in juvenile rats. Pharmacol Biochem Behav. 2012;101(1):77–84. doi: 10.1016/j.pbb.2011.12.006. [DOI] [PubMed] [Google Scholar]
  56. Shao L, Young LT, Wang JF. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry. 2005;58(11):879–884. doi: 10.1016/j.biopsych.2005.04.052. [DOI] [PubMed] [Google Scholar]
  57. Sheehan D, MEADE G, FOLEY VM. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J. 2001;360(1):1–6. doi: 10.1042/0264-6021:3600001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Shukla PK, Khanna VK, Ali MM, Maurya RR, Handa SS, Srimal RC. Protective effect of Acorus calamus against acrylamide induced neurotoxicity. Phytother Res. 2002;16(3):256–60. doi: 10.1002/ptr.854. [DOI] [PubMed] [Google Scholar]
  59. Sreenivasulu D, Balaji M. Rat brain glutathione S-transferases potentially defends acrylamide induced neurotoxicity and genotoxicity. IOSR-JBB. 2016;2(6):75–80. [Google Scholar]
  60. Srivastava S, Sabri MI, Agrawal AK, Seth PK. Effect of single and repeated doses of acrylamide and bis-acrylamide on glutathione-S-transferase and dopamine receptors in rat brain. Brain Res. 1986;371(2):319–23. doi: 10.1016/0006-8993(86)90369-0. [DOI] [PubMed] [Google Scholar]
  61. Struzynska L, Sulkowski G, Lenkiewicz A, Rafalowska U. Lead stimulates the glutathione system in selective regions of rat brain. Folia Neuropathol. 2002;40(4):203–209. [PubMed] [Google Scholar]
  62. Stadler RH, Blank I, Varga N, Robert F, Hau J, Guy PA, Robert MC, Riediker S. Food chemistry: acrylamide from Maillard reaction products. Nature. 2002;419(6906):449–450. doi: 10.1038/419449a. [DOI] [PubMed] [Google Scholar]
  63. Tansey FA, Cammer W. A Pi Form of Glutathione‐S‐Transferase Is a Myelin‐and Oligodendrocyte‐Associated Enzyme in Mouse Brain. Journal of neurochemistry. 1991;57(1):95–102. doi: 10.1111/j.1471-4159.1991.tb02104.x. [DOI] [PubMed] [Google Scholar]
  64. Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem. 2002;50(17):4998–5006. doi: 10.1021/jf020302f. [DOI] [PubMed] [Google Scholar]
  65. Van der Oost R, Beyer J, Vermeulen NP. Fish bioaccumulation and biomarkers in environmental risk assessment: a review. Environ Toxicol Pharmacol. 2003;13(2):57–149. doi: 10.1016/s1382-6689(02)00126-6. [DOI] [PubMed] [Google Scholar]
  66. Weiss G. Acrylamide in food: Uncharted territory. Science. 2002;297(5578):27. doi: 10.1126/science.297.5578.27a. [DOI] [PubMed] [Google Scholar]
  67. Wilce MC, Board PG, Feil SC, Parker MW. Crystal structure of a theta-class glutathione transferase. EMBO J. 1995;14(10):2133–2143. doi: 10.1002/j.1460-2075.1995.tb07207.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Yang HJ, Lee SH, Jin Y, Choi JH, Han CH, Lee MH. Genotoxicity and toxicological effects of acrylamide on reproductive system in male rats. J Vet Sci. 2005;6(2):103–109. [PubMed] [Google Scholar]
  69. Yousef MI, El-Demerdash FM. Acrylamide-induced oxidative stress and biochemical perturbations in rats. Toxicology. 2006;219(1):133–141. doi: 10.1016/j.tox.2005.11.008. [DOI] [PubMed] [Google Scholar]
  70. Zhang L, Gavin T, Barber DS, LoPachin RM. Role of the Nrf2-ARE pathway in acrylamide neurotoxicity. Toxicol Lett. 2011;205(1):1–7. doi: 10.1016/j.toxlet.2011.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Zhang M, Chen M, Tong W. Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans? Chem Res Toxicol. 2011;25(1):122–129. doi: 10.1021/tx200320e. [DOI] [PubMed] [Google Scholar]
  72. Zimniak P. Detoxification reactions: relevance to aging. Ageing Res Rev. 2008;7(4):281–300. doi: 10.1016/j.arr.2008.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Interdisciplinary Toxicology are provided here courtesy of Slovak Toxicology Society SETOX & Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences

RESOURCES